SAN DIEGO, CA, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTC-BB:SIGY), a development-stage medical technology company focused on addressing unmet needs in global health, announces that its securities will commence trading on the OTCQB® Venture Exchange at the open of today’s market. The Company’s securities, which previously traded on the OTC Pink Market, will continue to trade under the ticker symbol "SIGY".
Read more at globenewswire.comSigyn Therapeutics to Commence Trading on the OTCQB® Venture Exchange
Globe Newswire -
Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
